USFDA removes exemption given to IPCA Laboratories Ltd

The US FDA vide its e-mail dated 1st July, 2020 has intimated IPCA Laboratories Ltd that the shortage implications for Hydroxychloroquine Sulphate has changed and that it has been removed from list of drug products in shortage and therefore, the US FDA is removing the exemption given to us from the import alert for API and formulation of Hydroxychloroquine Sulphate.

Shares of IPCA LABORATORIES LTD. was last trading in BSE at Rs.1663.3 as compared to the previous close of Rs. 1671.2. The total number of shares traded during the day was 5827 in over 755 trades.

The stock hit an intraday high of Rs. 1684.15 and intraday low of 1623.85. The net turnover during the day was Rs. 9619365.

Source : Equity Bulls

Keywords